NDC 0407-1413

Omnipaque 300 mg per 1 mL injection, solution

On the label: GE Healthcare Inc..

Norway: 2China: 1Ireland: 1

Where it's made

FactoryWhereRoleLast FDA inspection
GE Healthcare (Shanghai) Co Ltd.China (Shanghai) Pilot Free Trade Zone, ChinaMakes it Problems found, fixed voluntarilyOct 30, 2025 · 6 inspections
GE Healthcare ASOslo, NorwayMakes it Problems found, fixed voluntarilyApr 23, 2024 · 8 inspections
GE Healthcare AS avd LindesnesLindesnes, NorwayMakes the active ingredient Problems found, fixed voluntarilyFeb 7, 2025 · 2 inspections
GE Healthcare Ireland LimitedCarrigtohill, IrelandMakes it Problems found, fixed voluntarilyNov 5, 2021 · 4 inspections

Recalls

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug
Iohexol: every company that makes it
Form
injection, solution, intravenous
Strength
300 mg per 1 mL
Approval
NDA NDA020608
On the market since
Dec 21, 2016
Package NDCs
0407-1413-72
Official label
DailyMed (National Library of Medicine), updated Apr 7, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?